Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Henderson JT, Webber EM, Sawaya GF. Screening for ovarian Cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(6):595–606.

Article  PubMed  Google Scholar 

Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, et al. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles. Cell Oncol (Dordrecht). 2020;43(4):515–38.

Article  Google Scholar 

Terry KL, Schock H, Fortner RT, Hüsing A, Fichorova RN, Yamamoto HS, et al. A prospective evaluation of early detection biomarkers for ovarian Cancer in the European EPIC cohort. Clin cancer Research: Official J Am Association Cancer Res. 2016;22(18):4664–75.

Article  CAS  Google Scholar 

Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295–303.

Article  PubMed  CAS  Google Scholar 

Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet (London England). 2021;397(10290):2182–93.

Article  PubMed  Google Scholar 

Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, et al. Screening for ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(6):588–94.

Article  PubMed  Google Scholar 

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (London England). 1999;353(9160):1207–10.

Article  PubMed  CAS  Google Scholar 

Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet (London England). 2016;387(10022):945–56.

Article  PubMed  Google Scholar 

Skates SJ, Pauler DK, Jacobs IJ. Screening based on the risk of Cancer calculation from bayesian hierarchical changepoint and mixture models of longitudinal markers. J Am Stat Assoc. 2001;96(454):429–39.

Article  Google Scholar 

Cramer DW, O’Rourke DJ, Vitonis AF, Matulonis UA, Dijohnson DA, Sluss PM, et al. CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clin Chem. 2010;56(12):1889–92.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Kjaerbye-Thygesen A, Gayther S, et al. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From the Danish MALOVA Ovarian Cancer Study. Gynecol Oncol. 2007;104(3):508–15.

Article  PubMed  Google Scholar 

Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncology: Official J Am Soc Clin Oncol. 2005;23(31):7919–26.

Article  Google Scholar 

Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncology: Official J Am Soc Clin Oncol. 2003;21(10 Suppl):s206–10.

Article  Google Scholar 

Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, et al. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ. 1996;313(7069):1355–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, et al. Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer. Gynecol Oncol. 2012;125(1):70–4.

Article  PubMed  Google Scholar 

Drescher CW, Shah C, Thorpe J, O’Briant K, Anderson GL, Berg CD, et al. Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. J Clin Oncology: Official J Am Soc Clin Oncol. 2013;31(3):387–92.

Article  Google Scholar 

Forstner R. Early detection of ovarian cancer. Eur Radiol. 2020;30(10):5370–3.

Article  PubMed  PubMed Central  Google Scholar 

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl):s273–309.

Article  Google Scholar 

Duffy MJ, Bonfrer JM, Kulpa J, Rustin GJ, Soletormos G, Torre GC, et al. CA125 in ovarian cancer: European Group on Tumor markers guidelines for clinical use. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2005;15(5):679–91.

Article  CAS  Google Scholar 

Blyuss O, Burnell M, Ryan A, Gentry-Maharaj A, Mariño IP, Kalsi J, et al. Comparison of longitudinal CA125 algorithms as a first-line screen for ovarian Cancer in the General Population. Clin cancer Research: Official J Am Association Cancer Res. 2018;24(19):4726–33.

Article  CAS  Google Scholar 

Menon U, Ryan A, Kalsi J, Gentry-Maharaj A, Dawnay A, Habib M, et al. Risk algorithm using serial biomarker measurements Doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncology: Official J Am Soc Clin Oncol. 2015;33(18):2062–71.

Article  Google Scholar 

Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, et al. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the prostate, lung, colorectal and ovarian (PLCO) trial. Int J Cancer. 2013;132(9):2127–33.

Article  PubMed  CAS  Google Scholar 

McIntosh MW, Drescher C, Fitzgibbon MM. Ovarian Cancer Early Detection needs better imaging, not better algorithms or biomarkers. J Clin Oncology: Official J Am Soc Clin Oncol. 2016;34(2):199–200.

Article  CAS  Google Scholar 

Einama T, Yamagishi Y, Takihata Y, Suzuki T, Yamasaki T, Hirose Y, et al. Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients. Biomark Res. 2021;9(1):78.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Wei Q, Dong D, Ren L. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer. Clin Chim Acta. 2021;523:19–25.

Article  PubMed  CAS  Google Scholar 

Yerushalmi R, Tyldesley S, Kennecke H, Speers C, Woods R, Knight B, et al. Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. Ann Oncol. 2012;23(2):338–45.

Article  PubMed  CAS  Google Scholar 

Einama T, Kamachi H, Nishihara H, Homma S, Kanno H, Takahashi K, et al. Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Pancreas. 2011;40(8):1276–82.

Article  PubMed  CAS  Google Scholar 

Bagan P, Berna P, Assouad J, Hupertan V, Le Pimpec Barthes F, Riquet M. Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax. Eur Respir J. 2008;31(1):140–2.

Article  PubMed  CAS  Google Scholar 

Xiao WB, Liu YL. Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis. J Gastroenterol Hepatol. 2003;18(11):1315–6.

Article  PubMed  Google Scholar 

Zuckerman E, Lanir A, Sabo E, Rosenvald-Zuckerman T, Matter I, Yeshurun D, et al. Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis. Am J Gastroenterol. 1999;94(6):1613–8.

Article  PubMed  CAS  Google Scholar 

Tyler C, Kapur A, Felder M, Belisle JA, Trautman C, Gubbels JA, et al. The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia. Am J Reprod Immunol. 2012;68(1):28–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Quirk JG Jr., Brunson GL, Long CA, Bannon GA, Sanders MM, O’Brien TJ. CA 125 in tissues and amniotic fluid during pregnancy. Am J Obstet Gynecol. 1988;159(3):644–9.